At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Comparison Between Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks
In Brief
A Phase 3 clinical trial evaluating intravenous 8 mg dexamethasone and perineural 0.8 ml of saline solution and intravenous 0,8 ml of saline solution and perineural 8 mg of dexamethasone for Brachial Plexus Block Duration. Completed, enrolled 150 participants across 3 sites in 2 countries.
Detailed Summary
Dexamethasone prolong the duration of brachial plexus blocks, but the optimal route, intravenous (IV) or perineural (PN), remains controversial. This Multi-centric trial compare IV and PN dexamethasone for ultrasound-guided axillary brachial plexus blocks (AXBs). Research hypothesis is that PN modality will outlast its IV counterpart. Since analgesic duration and sensory duration can be influenced by intake of pain medications and surgical trauma to small cutaneous nerves, the investigators will select motor block duration as the main outcome.